Trump announces new deal with pharma companies to cut drug prices
AI Summary
In December 2025, President Trump announced agreements with 14 of the 17 largest pharmaceutical companies to lower prescription drug prices in the United States. The deals aim to match U.S. drug prices to those of the developed nation with the lowest price, potentially through the TrumpRx website. Participating companies, including Bristol Myers Squibb, Gilead Sciences, and Merck, will cut prices on some drugs sold to the Medicaid program. In return, companies may receive a three-year tariff exemption. The goal is to reduce the high cost of prescription medicines for American patients, who currently pay significantly more than in other developed countries.
Key Entities & Roles
Keywords
Sentiment Analysis
Source Transparency
This article was automatically classified using rule-based analysis. The political bias score ranges from -1 (far left) to +1 (far right).
Topic Connections
Explore how the topics in this article connect to other news stories